GW Pharma Limited

CANTIVEX

Pharmaceutical and veterinary preparations, namely, herbal extracts, formulas containing herbal extracts, herbs and medicinal oils, for use in the treatment of multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness; herbs for medicinal purposes; pure extracts of herbs for medicinal purposes; medicinal infusions; foodstuffs for medicinal purposes; and herb teas for medicinal purposes.;

CEBEDEX

Pharmaceutical and veterinary preparations and substances for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, bone disorders, drug, alcohol and nicotine abuse; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical and veterinary preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, bladder disfunction, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse; herb teas for medicinal purposes;Color is not claimed as a feature of the mark.;

GREENWICH

Pharmaceutical and medical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols, for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical and medical preparations with cannabinoids as active ingredient, namely, a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances for the treatment of epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical preparations and substances for the treatment of convulsions and seizures associated with epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical and medical preparations for the treatment of symptoms associated with epilepsy including pain, muscle spasticity and spasms, bladder problems and sleep disorders associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; medicinal oils in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of epilepsy, convulsions and seizures associated with Dravet Syndrome and Lennox-Gestaut Syndrome;

GREENWICH ANIMAL HEALTH

Pharmaceutical and medical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols, for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical and medical preparations with cannabinoids as active ingredient, namely, a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances for the treatment of epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical preparations and substances for the treatment of convulsions and seizures associated with epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical and medical preparations for the treatment of symptoms associated with epilepsy including pain, muscle spasticity and spasms, bladder problems and sleep disorders associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; medicinal oils in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of epilepsy, convulsions and seizures associated with Dravet Syndrome and Lennox-Gestaut Syndrome;ANIMAL HEALTH;

GREENWICH BIOSCIENCES

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes;BIOSCIENCES;

GREENWICH BIOSCIENCES

Educational services, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, cancer treatment and cannabinoid medicines; instruction services in the field of pharmaceutical product development of medicines, cancer treatments and cannabinoid medicines;BIOSCIENCES;Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and new product design services relating thereto, all not involving cannabinoid medicines; chemical analysis not involving cannabinoid medicines; chemical research not involving cannabinoid medicines; research and development in the field of medicines, healthcare, and cancer treatment, not involving cannabinoid medicines; and Scientific and technological services, namely, scientific research, analysis, testing in the field of cannabinoid medicine development, and research and new product design services relating thereto, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical analysis involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical research involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; research and development in the field of cannabinoid medicines involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols;

GREENWICH BIOSCIENCES

Paper; cardboard and goods made from these materials, namely, boxes of cardboard; printed matter, namely, magazines devoted to medicine, healthcare, cancer treatment and cannabinoid medicines, books and pamphlets in the field of medicine, healthcare, cancer treatment and cannabinoid medicines, printed periodicals, general features magazines, employee newsletters all in the fields of medicine, healthcare, cancer treatment and cannabinoid medicines; books in the field of medicine, healthcare, cancer treatment and cannabinoid medicines; printed publications, namely, newspapers in the field of medicine, healthcare, cancer treatment and cannabinoid medicines; packaging materials for packages, namely, packaging containers of paper and cardboard; wrapping materials for packages, namely, wrapping paper, plastic film, plastic insulating materials, plastic protective wrapping; packaging boxes of paper, card or cardboard; stationery; printed instructional and teaching material in the field of medicines, healthcare, cancer treatment and cannabinoid medicines;BIOSCIENCES;

GREENWICH BOTANICALS

Pharmaceutical and medical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols, for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical and medical preparations with cannabinoids as active ingredient, namely, a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances for the treatment of epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical preparations and substances for the treatment of convulsions and seizures associated with epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical and medical preparations for the treatment of symptoms associated with epilepsy including pain, muscle spasticity and spasms, bladder problems and sleep disorders associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; medicinal oils in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of epilepsy, convulsions and seizures associated with Dravet Syndrome and Lennox-Gestaut Syndrome;BOTANICALS;

GW ANIMAL HEALTH

Pharmaceutical, medical and veterinary preparations and substances for animals; pharmaceutical medical and veterinary preparations for animals with cannabinoids as active ingredient; pharmaceutical preparations for animal skincare; pharmaceutical and veterinary preparations and substances for the treatment of epilepsy in animals; pharmaceutical and veterinary preparations and substances for the treatment of convulsions and seizures in animals; medications for animals for the treatment of multiple sclerosis, pain associated with cancer, neuropathies and rheumatoid arthritis; medicines for animals for the treatment of symptoms including pain, muscle spasticity and spasms, bladder problems and sleep disorders; medications for animals for the treatment of conditions to which neuropathic pain is associated, including multiple sclerosis, cancer, spinal cord injury, physical trauma and peripheral neuropathy resulting from diabetes; herbs for animals for medicinal purposes; medicinal herbs for animals; medicinal oils for animals; medicinal infusions for animals; medicinal infusions for animals for the treatment of epilepsy, convulsions and seizures; pure extracts of medicinal plants and herbs for animals; foodstuffs for medicinal purposes for animals and pets; medicated animal feed; medicated additives for animal feeds; dietary supplements for animals; dietetic food and substances for animals adapted for medical or veterinary use; herb teas for animals for medicinal purposes;Agricultural and horticultural products; seeds; seedlings for plant breeding; flowers; plants; plant residues (raw materials); fresh herbs; foodstuffs and beverages for animals; food for young animals;

GW BOTANICALS

Pharmaceutical, medical and veterinary preparations and substances; pharmaceutical preparations and substances for the treatment of epilepsy; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome and chromosome disorders; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; medicinal infusions for the treatment of epilepsy, convulsions and seizures; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; dietary supplements for humans and animals; dietetic food and substances adapted for medical or veterinary use; food for babies; herb teas for medicinal purposes; medications for the treatment of multiple sclerosis, pain associated with cancer, neuropathies and rheumatoid arthritis; medicines for the treatment of symptoms including pain, muscle spasticity and spasms, bladder problems and sleep disorders; medications for the treatment of conditions to which neuropathic pain is associated, including multiple sclerosis, cancer, spinal cord injury, physical trauma and peripheral neuropathy resulting from diabetes; medicines for the treatment of anorexia-cachexia, the result of cancer or AIDS, and nausea, and secondary vomiting due to chemotherapy treatments; pharmaceutical preparations with cannabinoids as active ingredient;Agricultural and horticultural products; seeds; seedlings for plant breeding; flowers; plants; plant residues (raw materials); fresh herbs; foodstuffs and beverages for animals;

GWP

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes;

GWPCARE

Educational services, namely, classes, seminars and workshops in the fields of clinical trials, educational matters and pharmaceutical preparations and substances; tuition training services in the field of clinical trials; provision of training and instruction services in the field of clinical trials, educational and pharmaceutical preparations and substances; publication of books and texts; publishing of electronic publications provision of online electronic publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational matter and pharmaceutical preparations and substances; arranging and conducting symposiums, conferences, congresses and exhibitions for educational purposes in the field of clinical trials, educational matter and pharmaceutical preparations and substances; advisory, information and consultancy services relating to all of the aforesaid;Computer programmes for collection, editing, organizing, modifying, managing, transmission, storage and sharing of data and information for use in relation to clinical trials, educational matters and pharmaceutical preparations and substances; computer software for collection, editing, organizing, modifying, managing, transmission, storage and sharing of data and information for use in relation to clinical trials, educational matters and pharmaceutical preparations and substances; data processing apparatus; pre-recorded optical discs featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; information stored on electronic, magnetic and/or by optical means, namely, audio and video recordings featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; downloadable electronic publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; electronic teaching publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances;Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; sanitary preparations for medical purposes; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes;Paper; printed matter, namely, books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational matter and pharmaceutical preparations and substances; packing materials of paper or cardboard; wrapping paper; packaging boxes of paper, paperboard or cardboard; stationery; photographs; printed instructional and teaching material in the field of clinical trials, educational and pharmaceutical preparations and substances; printed teaching and instructional material for research on health, drugs, pharmaceuticals, medical and technical laboratory matters;Medical services; healthcare services; veterinary services; medical analysis services, namely, medical consultations; horticultural services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals via the internet; providing medical information on the internet; advisory, information and consultancy services relating to all of the aforesaid;Surgical, medical, dental and veterinary apparatus, instruments and implements, namely, drug delivery systems; applicators for pharmaceutical preparations, namely, drug delivery systems; drug inhalation devices, namely, inhalers and nebulizers for medical purposes; apparatus for drug administration, namely, drug delivery systems; drug delivery devices, namely, medical syringes, and transdermal patches sold without medication; structural parts and fittings for all of the aforesaid goods;Agricultural seeds; flowers; live plants;Scientific and technological services, namely, scientific and technological research services relating to clinical trials and pharmaceutical preparations and substances; scientific research services; design services in the field of clinical trials and pharmaceutical preparations and substances; industrial design services; computer programming services; technical and scientific consultancy and research services in the field of clinical trials and pharmaceutical preparations and substances; testing and analysis of pharmaceutical preparations and substances; computerised analysis of scientific data; scientific laboratory services in the field of clinical trials and pharmaceutical preparations and substances; industrial analysis and research services in the field of clinical trials and pharmaceutical preparations and substances; medical research relating to epilepsy; analysis of medical research relating to epilepsy; chemical analysis services; chemical, biological, biotechnology and biomedical research services; research and development services in the field of clinical trials and pharmaceutical preparations and substances; conducting clinical trials for others; clinical research, namely, scientific research; providing medical research clinical trial information via a website; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory, information and consultancy services relating to all of the aforesaid;

GWPCARE CANNABIDIOL IN RESISTANT EPILEPSY

Educational services, namely, classes, seminars and workshops in the fields of clinical trials, educational matters and pharmaceutical preparations and substances; tuition training services in the field of clinical trials; provision of training and instruction services in the field of clinical trials, educational and pharmaceutical preparations and substances; publication of books and texts; publishing of electronic publications provision of online electronic publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational matter and pharmaceutical preparations and substances; arranging and conducting symposiums, conferences, congresses and exhibitions for educational purposes in the field of clinical trials, educational matter and pharmaceutical preparations and substances; advisory, information and consultancy services relating to all of the aforesaid;The mark consists of the stylized wording GWP CARE CANNABIDIOL IN RESISTANT EPILEPSY. The wording GWP appears in green in the upper left. The wording CARE appears in the upper right in blue. The wording CANNABIDIOL IN RESISTANT EPILEPSY appears in blue below the wording GWP CARE.;Computer programmes for collection, editing, organizing, modifying, managing, transmission, storage and sharing of data and information for use in relation to clinical trials, educational matters and pharmaceutical preparations and substances; computer software for collection, editing, organizing, modifying, managing, transmission, storage and sharing of data and information for use in relation to clinical trials, educational matters and pharmaceutical preparations and substances; data processing apparatus; pre-recorded optical discs featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; information stored on electronic, magnetic and/or by optical means, namely, audio and video recordings featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; downloadable electronic publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances; electronic teaching publications in the nature of books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational and pharmaceutical preparations and substances;Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; sanitary preparations for medical purposes; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes; all of the foregoing containing cannabidiol;Paper; printed matter, namely, books, periodicals, journals, magazines, newsletters and reports featuring information and promotional materials relating to clinical trials, educational matter and pharmaceutical preparations and substances; packing materials of paper or cardboard; wrapping paper; packaging boxes of paper, paperboard or cardboard; stationery; photographs; printed instructional and teaching material in the field of clinical trials, educational and pharmaceutical preparations and substances; printed teaching and instructional material for research on health, drugs, pharmaceuticals, medical and technical laboratory matters;GWP CARE CANNABIDIOL IN RESISTANT EPILEPSY;The color(s) green and blue is/are claimed as a feature of the mark.;Medical services; healthcare services; veterinary services; medical analysis services, namely, medical consultations; horticultural services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals via the internet; providing medical information on the internet; advisory, information and consultancy services relating to all of the aforesaid;Surgical, medical, dental and veterinary apparatus, instruments and implements, namely, drug delivery systems; applicators for pharmaceutical preparations, namely, drug delivery systems; drug inhalation devices, namely, inhalers and nebulizers for medical purposes; apparatus for drug administration, namely, drug delivery systems; drug delivery devices, namely, medical syringes, and transdermal patches sold without medication; structural parts and fittings for all of the aforesaid goods;CANNABIDIOL IN RESISTANT EPILEPSY;Agricultural seeds; flowers; live plants;Scientific and technological services, namely, scientific and technological research services relating to clinical trials and pharmaceutical preparations and substances; scientific research services; design services in the field of clinical trials and pharmaceutical preparations and substances; industrial design services; computer programming services; technical and scientific consultancy and research services in the field of clinical trials and pharmaceutical preparations and substances; testing and analysis of pharmaceutical preparations and substances; computerised analysis of scientific data; scientific laboratory services in the field of clinical trials and pharmaceutical preparations and substances; industrial analysis and research services in the field of clinical trials and pharmaceutical preparations and substances; medical research relating to epilepsy; analysis of medical research relating to epilepsy; chemical analysis services; chemical, biological, biotechnology and biomedical research services; research and development services in the field of clinical trials and pharmaceutical preparations and substances; conducting clinical trials for others; clinical research, namely, scientific research; providing medical research clinical trial information via a website; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory, information and consultancy services relating to all of the aforesaid;

GWPHARM

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes;GW PHARMACEUTICALS;

MYLIEF

Pharmaceutical preparations for the treatment of neurological conditions and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of neurological conditions and diseases; pure extracts of medicinal plants and herbs, namely, plant and herb extracts for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, dietetic foods adapted for medical use; herb teas for medicinal purposes; pharmaceutical preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; plant extracts for pharmaceutical purposes;

SATIV

Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the foregoing for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs for pharmaceutical use; foodstuffs for medicinal purposes; herb teas for medicinal purposes;

SATIV

Pharmaceutical and veterinary preparations; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; herb teas for medicinal purposes;

SATIVEX

Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pharmaceutical preparations for the treatment of neurological conditions and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the foregoing for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs for pharmaceutical use; foodstuffs for medicinal purposes; herb teas for medicinal purposes; pharmaceutical preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; plant extracts for pharmaceutical purposes;

SATIVEX

Pharmaceutical and veterinary preparations; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; herb teas for medicinal purposes;